The presence of mature LAMP3+ DCs within lymphoid follicles has been associated with improved prognosis in non-small cell lung cancer (NSCLC)12, but the effect of tumour CCR7+ DCs on prognosis in human cancers more broadly has not been examined. This evidence concerns the gene LAMP3 and cancer.